Silicosis clinical trials
The registry lists 20 studies for Silicosis across more than 10 countries. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-08-06.
Status
- Completed
- 9
- Status unknown
- 8
- Not yet recruiting
- 2
- Recruiting
- 1
Phase
- Phase 2
- 3
- Phase 1
- 2
- Phase 3
- 1
- Early Phase 1
- 1
Where
- China
- 4
- Australia
- 3
- United States
- 3
- Israel
- 2
- Brazil
- 2
- Zambia
- 1
Who runs them
Huashan Hospital (2) · Tel-Aviv Sourasky Medical Center (2) · The University of Queensland (2) · Wei Yu (1) · Centre for Infectious Disease Research in Zambia (1) · Chinese University of Hong Kong (1) · Universidade Federal do Rio de Janeiro (1) · National Heart, Lung, and Blood Institute (NHLBI) (1)
Studies
Recruiting first, then most recently updated. Showing 20 of 20 — search for more.
- Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective StudyNot yet recruitingNCT069229161 country
- Silicosis and Silicotuberculosis Among Small Scale Gemstone Miners in Northern TanzaniaRecruitingNCT064038001 country
- Using Silica 12CH to Mitigate the Effects and Symptoms of Silicosis in BrazilNot yet recruitingNCT06011785Early Phase 11 country
- KAP TB in Senior Management Officials of Companies With Increased Silica ExposureCompletedNCT077498721 country
- Reducing Silica Exposure Among Brick Kiln Workers in NepalCompletedNCT06090370Not applicable2 countries
- Screening Strategy for Early Diagnosis of Silicosis in At-Risk Populations in OklahomaCompletedNCT042057081 country
- Silicosis Treatment, Action, Screening and Surveillance in Rwanda TrialsStatus unknownNCT055382991 country
- The SHIELD Study-silicosisStatus unknownNCT055469441 country
- The SHIELD Whole Lung Lavage StudyStatus unknownNCT054021761 country
- Pirfenidone for the Reduction of Metabolic, Inflammatory and Fibrogenic Activity in Complicated SilicosisStatus unknownNCT05118256Phase 21 country
- The Nintedanib in Progressive Pneumoconiosis Study (NiPPS): a Collaborative NSW Treatment TrialStatus unknownNCT04161014Phase 21 country
- Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis PreventionCompletedNCT02430259Phase 31 country
- Short Course Rifapentine and Isoniazid for the Preventive Treatment of Tuberculosis(SCRIPT-TB)Status unknownNCT03900858Not applicable1 country
- Comprehensive Risk Assessment of People With Silicosis: A Population-based StudyCompletedNCT027947011 country
- Specialized Center of Research in Occupational and Immunologic Lung DiseaseCompletedNCT00005280
- Safety of Stem Cells Intrabronchial Instillation for SilicosisCompletedNCT01239862Phase 11 country
- Oscillation Mechanics of the Respiratory System in Never-smoking Patients With SilicosisCompletedNCT017259711 country
- Safety Study of Autologous Bone Marrow Stromal Cells With Modification by Hepatocyte Growth Factor to Treat SilicosisCompletedNCT01977131Phase 1/2
- Oxidative Stress Biomarkers to Monitor and Early Detect Health Impairment in Workers Exposed to Silica (Caesar Stone)Status unknownNCT013380641 country
- DNA-damage Pathways in Workers Exposed to Silica (Caesar Stone)Status unknownNCT013290031 country